Previous close | 18.18 |
Open | 18.16 |
Bid | 18.11 x 100 |
Ask | 18.17 x 200 |
Day's range | 18.11 - 18.18 |
52-week range | 3.89 - 18.31 |
Volume | |
Avg. volume | 2,130,106 |
Market cap | 2.74B |
Beta (5Y monthly) | 0.61 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript March 14, 2024 MorphoSys AG isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen. Welcome and thank you for joining MorphoSys Full Year 2023 Results and Business Update […]
Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys are part of the Zacks top Analyst Blog.
We have narrowed our search to five biotech stocks with strong potential for 2024. These are MOR, LEGN, ASND, EXEL and EXAS.